ACS Catalysis
Page 10 of 11
CYP106A2 - Production of Pharmaceutically Interesting DHEA
(34) Fasan, R. Tuning P450 Enzymes as Oxidation Catalysts. ACS
Metabolites. Microb. Cell. Fact. 2014, 13, 81.
Catal. 2012, 2 (4), 647–666.
1
2
3
4
5
6
7
8
(19) Putkaradze, N.; Kiss, F. M.; Schmitz, D.; Zapp, J.; Hutter, M.
C.; Bernhardt, R. Biotransformation of Prednisone and Dexamethasone
by Cytochrome P450 Based Systems - Identification of New Potential
Drug Candidates. J. Biotechnol. 2017, 242, 101–110.
(20) Khatri, Y.; Ringle, M.; Lisurek, M.; von Kries, J. P.; Zapp, J.;
Bernhardt, R. Substrate Hunting for the Myxobacterial CYP260A1
Revealed New 1-Hydroxylated Products from C-19 Steroids.
Chembiochem 2016, 17 (1), 90–101.
(21) Khatri, Y.; Carius, Y.; Ringle, M.; Lancaster, C. R.; Bernhardt,
R. Structural Characterization of CYP260A1 from Sorangium
cellulosum to Investigate the 1-Hydroxylation of a Mineralocorticoid.
FEBS Lett. 2016, 590 (24), 4638–4648.
(22) Khatri, Y.; Jozwik, I. K.; Ringle, M.; Ionescu, I. A.;
Litzenburger, M.; Hutter, M. C.; Thunnissen, A. W. H.; Bernhardt, R.
Structure-Based Engineering of Steroidogenic CYP260A1 for Stereo-
and Regioselective Hydroxylation of Progesterone. ACS Chem. Biol.
2018, 13 (4), 1021–1028.
(23) Bracco, P.; Janssen, D. B.; Schallmey, A. Selective Steroid
Oxyfunctionalisation by CYP154C5, a Bacterial Cytochrome P450.
Microb. Cell Fact. 2013, 12, 95.
(24) Makino, T.; Katsuyama, Y.; Otomatsu, T.; Misawa, N.;
Ohnishi, Y. Regio- and Stereospecific Hydroxylation of Various
Steroids at 16 Position of the D Ring by the Streptomyces griseus
Cytochrome P450 CYP154C3. Appl. Environ. Microbiol. 2014, 80 (4),
1371–1379.
(35) Whitehouse, C. J. C.; Bell, S. G.; Wong, L. L. P450BM3
(CYP102A1): Connecting the Dots. Chem. Soc. Rev. 2012, 41 (3),
1218–1260.
(36) Urlacher, V. B.; Girhard, M. Cytochrome P450
Monooxygenases in Biotechnology and Synthetic Biology. Trends
Biotechnol. 2019, 37 (8), 882–897.
(37) Pflug, S.; Richter, S. M.; Urlacher, V. B. Development of a Fed-
Batch Process for the Production of the Cytochrome P450
Monooxygenase CYP102A1 from Bacillus megaterium in E. coli. J.
Biotechnol. 2007, 129 (3), 481–488.
(38) Kaluzna, I.; Schmitges, T.; Straatman, H.; van Tegelen, D.;
Muller, M.; Schurmann, M.; Mink, D. Enabling Selective and
Sustainable P450 Oxygenation Technology. Production of 4-Hydroxy-
alpha-isophorone on Kilogram Scale. Org. Process Res. Dev. 2016, 20
(4), 814–819.
(39) Ren, X. K.; O'Hanlon, J. A.; Morris, M.; Robertson, J.; Wong,
L. L. Synthesis of Imidazolidin-4-ones via a Cytochrome P450-
Catalyzed Intramolecular C-H Amination. ACS Catal. 2016, 6 (10),
6833-6837.
(40) Syntrivanis, L. D.; Wong, L. L.; Robertson, J. Hydroxylation of
Eleuthoside Synthetic Intermediates by P450BM3 (CYP102A1). Eur.
J. Org. Chem. 2018, (45) 6369–6378.
(41) Li, Y.; Wong, L. L. Multi-Functional Oxidase Activity of
CYP102A1 (P450BM3) in the Oxidation of Quinolines and
Tetrahydroquinolines. Angew. Chem. Int. Ed. 2019, 58 (28), 9551–
9555.
(42) Haines, D. C.; Tomchick, D. R.; Machius, M.; Peterson, J. A.
Pivotal Role of Water in the Mechanism of P450BM-3. Biochemistry
2001, 40 (45), 13456–13465.
(43) Ghosh, D.; Egbuta, C.; Lo, J. Testosterone Complex and Non-
Steroidal Ligands of Human Aromatase. J. Steroid Biochem. Mol. Biol.
2018, 181, 11–19.
(44) Yildirim, K.; Kuru, A. Microbial Hydroxylation of
Epiandrosterone by Aspergillus candidus. Biocatal. Biotransformation
2017, 35 (2), 120–126.
(45) Peart, P. C.; McCook, K. P.; Russell, F. A.; Reynolds, W. F.;
Reese, P. B. Hydroxylation of Steroids by Fusarium oxysporum,
Exophiala jeanselmei and Ceratocystis paradoxa. Steroids 2011, 76
(12), 1317–1330.
(46) Koshimura, M.; Utsukihara, T.; Hara, A.; Mizobuchi, S.;
Horiuchi, C. A.; Kuniyoshi, M. Hydroxylation of Steroid Compounds
by Gelasinospora retispora. J. Mol. Catal. B Enzym. 2010, 67 (1-2),
72–77.
(47) Kobayashi, M.; Mitsuhashi, H. Marine Sterols. XIII. Isolation
and Synthesis of 1,3,5,6-Tetrahydroxy-5-androstan-17-one from
the Soft Coral Sarcophyton glaucum. Steroids 1982, 40 (6), 673–677.
(48) Whitehouse, C. J. C.; Bell, S. G.; Tufton, H. G.; Kenny, R. J.;
Ogilvie, L. C.; Wong, L. L. Evolved CYP102A1 (P450BM3) Variants
Oxidise a Range of Non-Natural Substrates and Offer New Selectivity
Options. Chem. Commun. 2008, 44 (8), 966–968.
(49) Abraham, M. J.; Murtola, T.; Schulz, R.; Páll, S.; Smith, J. C.;
Hess, B.; Lindahl, E. GROMACS: High Performance Molecular
Simulations Through Multi-Level Parallelism from Laptops to
Supercomputers. SoftwareX 2015, 1-2, 19–25.
(50) Petrovic, D.; Bokel, A.; Allan, M.; Urlacher, V. B.; Strodel, B.
Simulation-Guided Design of Cytochrome P450 for Chemo- and
Regioselective Macrocyclic Oxidation. J. Chem. Inf. Model. 2018, 58
(4), 848–858.
(51) Shahrokh, K.; Orendt, A.; Yost, G. S.; Cheatham, T. E., 3rd
Quantum Mechanically Derived AMBER-Compatible Heme
Parameters for Various States of the Cytochrome P450 Catalytic Cycle.
J. Comput. Chem. 2012, 33 (2), 119–133.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(25) van Vugt-Lussenburg, B. M.; Damsten, M. C.; Maasdijk, D.
M.; Vermeulen, N. P.; Commandeur, J. N. Heterotropic and
Homotropic Cooperativity by
a Drug-Metabolising Mutant of
Cytochrome P450 BM3. Biochem. Biophys. Res. Commun. 2006, 346
(3), 810–818.
(26) van Vugt-Lussenburg, B. M.; Stjernschantz, E.; Lastdrager, J.;
Oostenbrink, C.; Vermeulen, N. P.; Commandeur, J. N. Identification
of Critical Residues in Novel Drug Metabolizing Mutants of
Cytochrome P450 BM3 Using Random Mutagenesis. J. Med. Chem.
2007, 50 (3), 455–461.
(27) Rea, V.; Kolkman, A. J.; Vottero, E.; Stronks, E. J.; Ampt, K.
A.; Honing, M.; Vermeulen, N. P.; Wijmenga, S. S.; Commandeur, J.
N. Active Site Substitution A82W Improves the Regioselectivity of
Steroid Hydroxylation by Cytochrome P450 BM3 Mutants as
Rationalized by Spin Relaxation Nuclear Magnetic Resonance Studies.
Biochemistry 2012, 51 (3), 750–760.
(28) Venkataraman, H.; Beer, S. B.; Bergen, L. A.; Essen, N.;
Geerke, D. P.; Vermeulen, N. P.; Commandeur, J. N. A Single Active
Site Mutation Inverts Stereoselectivity of 16-Hydroxylation of
Testosterone Catalyzed by Engineered Cytochrome P450 BM3.
Chembiochem 2012, 13 (4), 520–523.
(29) Ren, X.; Yorke, J. A.; Taylor, E.; Zhang, T.; Zhou, W.; Wong,
L. L. Drug Oxidation by Cytochrome P450BM3: Metabolite Synthesis
and Discovering New P450 Reaction Types. Chem. Eur. J. 2015, 21
(42), 15039-15047.
(30) Kille, S.; Zilly, F. E.; Acevedo, J. P.; Reetz, M. T. Regio- and
Stereoselectivity of P450-Catalysed Hydroxylation of Steroids
Controlled by Laboratory Evolution. Nat. Chem. 2011, 3 (9), 738–743.
(31) Acevedo-Rocha, C. G.; Gamble, C. G.; Lonsdale, R.; Li, A. T.;
Nett, N.; Hoebenreich, S.; Lingnau, J. B.; Wirtz, C.; Fares, C.;
Hinrichs, H.; Deege, A.; Mulholland, A. J.; Nov, Y.; Leys, D.; McLean,
K. J.; Munro, A. W.; Reetz, M. T. P450-Catalyzed Regio- and
Diastereoselective Steroid Hydroxylation: Efficient Directed Evolution
Enabled by Mutability Landscaping. ACS Catal. 2018, 8 (4), 3395–
3410.
(32) Li, A.; Acevedo-Rocha, C. G.; D'Amore, L.; Chen, J.; Peng, Y.;
Garcia-Borras, M.; Gao, C.; Zhu, J.; Rickerby, H.; Osuna, S.; Zhou, J.;
Reetz, M. T. Regio- and Stereoselective Steroid Hydroxylation at the
C7-Position by Cytochrome P450 Monooxygenase Mutants. Angew.
Chem. Int. Ed. 2020, DOI:10.1002/anie.202003139.
(52) Trott, O.; Olson, A. J. AutoDock Vina: Improving the Speed
and Accuracy of Docking with a New Scoring Function, Efficient
Optimization, and Multithreading. J. Comput. Chem. 2010, 31 (2),
455–461.
(33) Jung, S. T.; Lauchli, R.; Arnold, F. H. Cytochrome P450:
Taming a Wild Type Enzyme. Curr. Opin. Biotechnol. 2011, 22 (6),
809–817.
10
ACS Paragon Plus Environment